The article highlights the latest advances presented at the ATTD Conference on diabetes technologies and treatments, emphasizing three major trends:

1. New technologies and medications for all types of diabetes

• Tools such as automated insulin pumps and continuous glucose monitors (CGM) are no longer exclusive to one type of diabetes; they now benefit people with type 1, type 2, and even prediabetes.
• GLP-1 medications (like tirzepatide and semaglutide) show benefits beyond glycemic control, helping with heart failure, sleep apnea, liver disease, and weight loss, and may even be used in type 1 diabetes.
• Gender equity in technology is improving glycemic control for women, especially during hormonal changes.

2. New targets in glycemic control

• New metrics such as TITR (time in tight range) and TING (time in normal glucose) are being introduced, aiming for even more precise glucose control.
• However, experts caution that demanding such strict ranges may be unrealistic for people living with diabetes, due to the many factors that affect glucose levels.

3. Toward a possible cure

Trending

Reliable Transport Services: Your Trusted Partner in Non-Emergency Medical Transportation

• There are advances in pancreas and islet cell transplants, as well as encapsulation devices that protect new beta cells from the immune system.
• Research is underway to “retrain” the immune system to prevent it from attacking the pancreas.
• These developments, though still under investigation, bring the possibility of a cure closer and improve the quality of life for people with diabetes.

Conclusion:
The future of diabetes treatment is becoming increasingly personalized, with technologies and medications breaking down barriers between diabetes types and offering real hope for better outcomes and, eventually, a cure.

Source: beyondtype1